WASHINGTON (Reuters) - Most men over age 75 can safely discontinue screening for prostate cancer with the PSA blood test, although such screening may still benefit some older men, U.S. researchers said on Friday.
WASHINGTON (Reuters) - Most men over age 75 can safely discontinue screening for prostate cancer with the PSA blood test, although such screening may still benefit some older men, U.S. researchers said on Friday.
